Guyana

in page functions
[French]
Guyana
Total population (2019) 782,567
Birth cohort (2019) 15,699
Surviving Infants (surviving to 1 year per year, 2019) 15,034
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 32/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 39/1000
World Bank Index, IDA (2015) 3.33
Gross Nation Income (per capita US$, 2015) 4,090
No. of districts/territories (2018) 13
Download this page as a PDF factsheet

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Guyana

Type of support

Approvals

2001-2023 (US$)
(17 Sep 2019)

Commitments

2001-2023 (US$)
(17 Sep 2019)

Disbursements

2000-2019 (US$)
(17 Sep 2019)

% Disbursed

(17 Sep 2019)
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $4,650,793 $4,650,793 $4,378,088
Graduation grant (GG) $368,000 $368,000 $368,000 100%
HPV (NVS) $49,500 $49,500 $49,500 100%
HPV MAC (NVS) $39,000 $39,000 $39,000 100%
HPV MAC - Op costs (OPC) $3,675 $3,675 $3,675 100%
Immunisation services support (ISS) $65,454 $65,454 $65,454 100%
Injection Safety Devices (NVS) $5,000 $5,000 $3,500 70%
IPV (NVS) $227,500 $227,500 $158,500 70%
Penta (NVS) $924,058 $924,058 $924,058 100%
Pneumo (NVS) $1,187,106 $1,187,106 $1,239,901 104%
Rotavirus (NVS) $1,281,500 $1,281,500 $1,026,500 80%
Vaccine Introduction Grant (VIG) $500,000 $500,000 $500,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Guyana DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2018)

Grade of confidence

N/A
DTP3 - Official country estimates (2018) 95%
M:F sex ratio at birth (2019) 1.05
Household survey: DTP3 coverage for male (2013) 90.90%
Household survey: DTP3 coverage for female (2013) 90.90%
Household survey: Last DTP3 survey (2013) 91%
% districts achieving > 80% DTP3 coverage (2018) 100%
% districts achieving < 50% DTP3 coverage (2018) 0%
MCV WHO/UNICEF estimates (2018) 98%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$937,129 $3,440,959

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Guyana

18 October 2019

Kenya HPV

Kenya introduces cervical cancer vaccine nationally

Approximately 800,000 girls to be protected annually through introduction of HPV vaccine into routine immunisation programme.

12 November 2015

Mothers attending the launch ceremony of the PCV vaccine in Guinea Bissau, june 2015.

Unprecedented number of children protected against pneumonia with Gavi support

As the international community marks the seventh World Pneumonia Day, Gavi pneumococcal and pentavalent vaccines are reaching children at an accelerated pace.

13 July 2015

Alwaleed statement - Kiribati

Alwaleed Philanthropies to support childhood immunisation with US$ 1 million pledge

Funding will cover the costs of vaccines in six countries.

Useful links

View all sources for data in this page

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here